MedTrace Logo

Deep Brain Stimulation Effects in Patients With Chronic Refractory Obesity

NCT04453020 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-01-27

No results posted yet for this study

Summary

This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the lateral hypothalamic area (LHA) as a treatment for chronic refractory obesity. This study will include 6 individuals with chronic refractory obesity, that have failed other treatments including gastric bypass surgery.

Conditions

Interventions

DEVICE

DBS of the LHA

Deep Brain Stimulation of the Lateral Hypothalamic Area

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • donald whiting

    lead OTHER

Principal Investigators

  • Donald Whiting, MD · Allegheny Health Network

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-07
Primary Completion
2024-11-01
Completion
2024-11-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04453020 on ClinicalTrials.gov